NCT01258140

Brief Summary

Computed tomography pulmonary angiography (CTPA) is the imaging method of choice to rule out acute pulmonary embolism based on its high sensitivity and specificity. Unfortunately, CTPA uses iodinated contrast media and can provoke contrast induced nephropathy. On the other hand, Computed tomography uses ionising radiation and is responsible for the half of the radiation exposure coming from medical sources. Recent studies have proven that low-dose CTPA protocols using Computed tomography tube energy of 80 kVp and reduced volume of iodinated contrast media provide an increased vessel signal and good image quality at a significantly reduced patient exposure. However, there are no data on the sensitivity of low-kVp protocols. The aim of this prospective randomized trial is to detect any difference between a normal-dose and a low-dose CTPA protocol in the diagnostic accuracy in the detection of acute pulmonary embolism (PE).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
504

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2008

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2008

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

December 6, 2010

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 10, 2010

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
Last Updated

January 23, 2013

Status Verified

January 1, 2013

Enrollment Period

4.3 years

First QC Date

December 6, 2010

Last Update Submit

January 21, 2013

Conditions

Keywords

CT angiographyradiation dosecontrast medium

Outcome Measures

Primary Outcomes (2)

  • Evidence of Pulmonary Embolism (PE) on CT pulmonary angiography (CTPA)

    1 hour after CTPA

  • Accuracy of normal- and low-dose CTPA on composite reference standard

    90 days after CTPA

Secondary Outcomes (4)

  • Evidence of PE or deep venous thrombosis in 90 days following CTPA

    90 days after CTPA

  • PE-related death in 90 days after CTPA

    90 days after CTPA

  • Diagnostic confidence with normal- and low-dose CTPA

    2 months after recruitment of last patient

  • Radiation dose with both CTPA protocols

    2 months after recruitment of last patient

Study Arms (2)

1

ACTIVE COMPARATOR

Patients examined with normal-dose Computed tomography pulmonary angiography

Radiation: Computed tomography pulmonary angiography

2

ACTIVE COMPARATOR

Patients examined with low-dose Computed tomography pulmonary angiography

Radiation: Computed tomography pulmonary angiography

Interventions

CT pulmonary angiography using iodinated contrast agent

1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • CTPA (CT pulmonary angiography) indicated based on clinical suspicion for pulmonary embolism
  • patient's body weight \< 100 kg
  • informed consent form signed by patient

You may not qualify if:

  • contraindication to iodinated contrast media
  • pregnancy (if alternative imaging methods to exclude pulmonary embolism are available)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Diagnostic, Interventional and Pediatric Radiology, University Hospital Bern

Bern, Canton of Bern, 3010, Switzerland

Location

MeSH Terms

Conditions

Pulmonary Embolism

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesEmbolismEmbolism and ThrombosisVascular DiseasesCardiovascular Diseases

Study Officials

  • Zsolt Szucs-Farkas, MD, PhD

    Institute of Diagnostic, Interventional and Pediatric Radiology, University Hospital Bern

    PRINCIPAL INVESTIGATOR
  • Zsolt Szucs-Farkas, MD, PhD

    Hospital Centre Biel, Vogelsang 84, CH-2502 Biel/Bienne

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

December 6, 2010

First Posted

December 10, 2010

Study Start

September 1, 2008

Primary Completion

December 1, 2012

Study Completion

December 1, 2012

Last Updated

January 23, 2013

Record last verified: 2013-01

Locations